Electra Therapeutics, Inc. Common stock (ETRA)

• Market cap: $490M
• 1 day: 6.12%
• 5 days: -4.18%
• 1 month: -20.57%
• 3 months: -41.13%
• 6 months: -41.13%
• Year to date: -41.13%
• 1 year: -41.13%
• 5 years: -41.13%
• 10 years: -41.13%
• Sector: Healthcare
• Industry: Biotechnology

About: Electra Therapeutics Inc is a late clinical-stage biopharmaceutical company focused on pioneering a new class of precision medicines for the treatment of immune-mediated diseases and cancer. The company's pipeline includes Ipsoprubart and ELA822.